Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer.
- DOI
- 10.1007/s10549-010-1066-x
- Published
- 2010 Sep
- Container
- Breast cancer research and treatment
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10549-010-1066-x,
title = {Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer.},
author = {Wildiers H and Fontaine C and Vuylsteke P and Martens M and Canon JL and Wynendaele W and Focan C and De Greve J and Squifflet P and Paridaens R},
year = {2010},
journal = {Breast cancer research and treatment},
doi = {10.1007/s10549-010-1066-x},
url = {https://doi.org/10.1007/s10549-010-1066-x}
}RIS
TY - JOUR TI - Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer. AU - Wildiers H AU - Fontaine C AU - Vuylsteke P AU - Martens M AU - Canon JL AU - Wynendaele W AU - Focan C AU - De Greve J AU - Squifflet P AU - Paridaens R PY - 2010 JO - Breast cancer research and treatment DO - 10.1007/s10549-010-1066-x UR - https://doi.org/10.1007/s10549-010-1066-x ER -
APA
H, W., C, F., P, V., M, M., JL, C., W, W., C, F., J, D. G., P, S., & R, P. (2010). Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer.. Breast cancer research and treatment. https://doi.org/10.1007/s10549-010-1066-x
Source records
- pubmed · retrieved 2026-09-26T05:45:36.162Z